News

From 2000 to 2021, there was an increase in the incidence of pancreatic adenocarcinoma, which was seen in all age groups, ...
This discovery opens the door for new kinds of treatments. If doctors could develop drugs that block CD9 or stop cancer cells ...
Between 2000 and 2021, there was an increased incidence of pancreatic adenocarcinoma and a decrease in the incidence of colorectal cancer seen across age groups. HealthDay News — From 2000 to ...
Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...
Antibody-drug conjugates continue to show benefits in breast cancer, plus the FDA has fast-tracked an innovative AI tool to help identify pancreatic tumors.
Less time in a chair and more time on the move, even if it’s a stroll versus a sprint, is the key to keeping cancer at bay.
There has been a sharp increase in colorectal and pancreatic cancer rates among Americans under 55 years, despite declines in ...
A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the ...